Healthcare AI — Market

Verified claims and product-axis read for Healthcare AI. Every fact below is sourced; every product judgment traces back to underlying signals.

Verified facts

• Abridge, an ambient clinical-documentation platform, reached a ~$5.3B valuation, making it one of the most valuable healthcare-AI companies. ↗ (financial)
• OpenEvidence, an AI medical-evidence search tool for clinicians, reached a ~$12B valuation in 2026. ↗ (financial)
• Ambience Healthcare, which provides ambient AI documentation and coding for health systems, is valued at ~$1.25B. ↗ (financial)
• Hippocratic AI builds patient-facing healthcare voice agents focused on non-diagnostic tasks such as follow-ups and screening. ↗ _(technical_spec)_
• Tennr uses AI to automate patient referrals and intake from faxes and unstructured documents. ↗ _(technical_spec)_
• Healthcare drew roughly 40% of application-layer AI funding in 2025, prompting the 'healthcare is the new dev tools' framing among investors. ↗ (other)
• Ambient clinical scribing — automatically transcribing and structuring doctor-patient conversations into notes — is the breakout healthcare-AI product category. ↗ (other)
• Abridge and Ambience compete to embed ambient documentation directly into electronic-health-record workflows, including deep Epic integrations. ↗ (other)
• OpenEvidence positions itself as a point-of-care medical search engine for physicians, distinct from the ambient-scribe vendors, and grew rapidly in clinician adoption. ↗ _(technical_spec)_
• Healthcare-AI buyers increasingly evaluate vendors on clinician-time saved and documentation accuracy rather than raw model benchmarks. ↗ (other)

See the Products and Strategy modules for the full product list and forward-looking judgment.